Navigation Links
Prometheus Laboratories and UCLA Sign Agreement to Validate Biological Markers of Mucosal Healing in IBD
Date:12/9/2010

SAN DIEGO, Dec. 9, 2010 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and The Regents of the University of California, Los Angeles campus, today announced the execution of an exclusive research agreement that will focus on the identification of biological markers of mucosal healing in patients with Inflammatory Bowel Disease (IBD). The research will be led by Dr. Jonathan Braun, Chair of the Department of Pathology and Laboratory Medicine and a professor of molecular and medical pharmacology, UCLA David Geffen School of Medicine.

Using a cross sectional study design, Dr. Braun's laboratory will determine the correlation of genotoxicity markers to mucosal healing and disease activity in IBD patients. Prometheus will evaluate in its laboratory, additional markers of inflammation and other markers traditionally associated with the diagnosis and prognosis of IBD.

"We have come to realize that symptom response is not a true indication that a drug has been effective in stopping the progression of IBD. We need to look at mucosal healing as a more accurate predictor of effective response," said Dr. Jonathan Braun. "There is a clinical need for a non-invasive biomarker of mucosal healing as currently this has been seen using a colonoscopy."

"Adding this research project to our R&D portfolio is the latest in a series of investments Prometheus has made to answer the clinical questions related to optimization of the use of biologic therapies commonly used in IBD treatment," said Joseph M. Limber, President & Chief Executive Officer of Prometheus. "Our goal is to be able to answer the clinical questions of who will respond to these drugs up front, how one can manage patients most effectively while on these drugs and to have a non-invasive measurement of treatment efficacy."

Under the terms of the exclusive agreement, Prometheus will fund the research activities in Dr. Braun's laboratory in exchange for rights to any intellectual property generated as a result of the project. Prometheus holds a license to technology Dr. Braun co-invented and Dr. Braun is a co-founder of Prometheus. 

About Prometheus

Prometheus Laboratories Inc. is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and is applying these principles to oncology. Its strategy includes the marketing and delivery of pharmaceutical products complemented by proprietary diagnostic testing services. By integrating therapeutics and diagnostics, Prometheus believes it can provide physicians with more targeted solutions to optimize care for their patients. Prometheus' corporate offices are located in San Diego, California.


'/>"/>
SOURCE Prometheus Laboratories Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Prometheus Research Launches Solutions Group to Springboard HTSQL-based Solutions for Customers
2. Prometheus and Tarrot Laboratories Collaborate to Identify Markers Associated With Response to Anti-TNF Therapies in Crohns Disease
3. Prometheus Research Informatics Technology Enables Multiple Presentations at IMFAR
4. Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software
5. DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID™ Genetic Test
6. Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research
7. Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome
8. Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
9. Terso Solutions RFID Jump Start Takes the Risk Out of Implementing RFID for Hospitals and Research Laboratories Looking to Streamline Operations and Improve Regulatory Compliance
10. MO BIO Laboratories, Inc. DNA Isolation Products Used to Analyze Microbes Present in Deepwater Horizon Oil Plume
11. Forensic Laboratories Develops First Oral Fluid Test for Ethyl Sulfate Detection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... announced today that they have entered into a multiyear collaboration to identify and ... researchers with additional tools for gene editing across all applications. , Under the ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
Breaking Biology Technology:
(Date:8/15/2017)... --  ivWatch LLC , a medical device company focused on improving ... of its ISO 13485 Certification, the global standard for medical device ... (ISO®). ... Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it ...
(Date:6/23/2017)... and ITHACA, N.Y. , June 23, ... University, a leader in dairy research, today announced a ... to help reduce the chances that the global milk ... of this dairy project, Cornell University has become the ... the Food Supply Chain, a food safety initiative that ...
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
Breaking Biology News(10 mins):